Implementation of Teleophthalmology in Urban Health Systems Study
Running, not enrolling · Not applicable
Conditions studied: Diabetic Retinopathy
In brief
This study is being conducted to test the effectiveness of I-SITE (Implementation for Sustained Impact in Teleophthalmology), an implementation program to sustain increased diabetic eye screening rates using teleophthalmology in urban, multi-payer health systems.
Key facts
- Study ID
- NCT05773495
- Run by
- University of Wisconsin, Madison
- People needed
- 12840
- Starts
- 2024-03-19
- Expected to finish
- 2028-12-31
- Last updated by the study team
- 2026-02-13
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Eligible medical records will be identified using ICD-10 codes for diabetes type 1 or type 2
- Billing data will be identified using teleophthalmology (CPT codes 92228 or 92250)
- Identification of eligible records will be performed by clinic personnel at each health system who already have full access to their patient data as part of their employment, and regularly gather and report this type of data to health insurers as part of their clinical role
Where it is running
- University of Wisconsin — Madison, Wisconsin, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.